Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

41.97
-0.5600-1.32%
Volume:7.54M
Turnover:317.56M
Market Cap:187.40B
PE:10.48
High:42.72
Open:42.47
Low:41.81
Close:42.53
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.12
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:4.10%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.75
PE(LYR):11.59

Loading ...

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

TIPRANKS
·
Aug 20

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Novo-Nordisk A/S Rises 3.02% in Regular Trading, Launches Low-Dose Oral Weight Loss Drug Clinical Trial

Market Focus
·
Aug 19

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

Dow Jones
·
Aug 19

Novo Nordisk Launches Dosage Study for Oral Semaglutide

MT Newswires Live
·
Aug 19

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

TIPRANKS
·
Aug 19

BMO Capital Remains a Hold on Novo Nordisk (NVO)

TIPRANKS
·
Aug 18

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

TIPRANKS
·
Aug 18

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 18

Novo Nordisk downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Aug 17

Novo, LightPath, Jasper, UMAC, CCEP Trending With Analysts

TIPRANKS
·
Aug 15

Novo Nordisk Completes Key Oral Semaglutide Study in Japan: What Investors Should Watch

TIPRANKS
·
Aug 14

Novo Nordisk’s SEMA-CardioDiab Hungary Study: What Real-World Oral Semaglutide Data Could Mean for NVO Investors

TIPRANKS
·
Aug 14